07 Jan 2001

Milurit® | (Milurit®/-300 Tabletten) - Deutschland

Updated: 07 Jan 2001

Milurit® | -300

Gicht, Prophylaxe und Therapie sekundärer Hyperurikämien.

Milurit® | Description, Presentation and Dosage

Milurit® | Description

Milurit® | Drug Class Description


Milurit® | Drug Description

1 Tbl. enth.: Allopurinol 100 mg/300 mg.

Milurit® | Generic Name

Milurit®/-300 Tabletten

Milurit® | Presentation

Milurit® | Presentation


Milurit® | Manufacturer


Related Learning Zones

Heart Failure

Heart Failure is a progressive chronic disorder that results in the inability of the heart to pump blood efficiently to the bodys tissues.

Chronic heart failure is an increasing public health problem; the growing prevalence in industrialised countries means that 1-2% of the adult population of these countries are now thought to have chronic heart failure.1-3 Estimates suggest that the prevalence in Europe, USA and Japan could increase by approximately 16.5% over the next ten years.4

Type 2 Diabetes

Type 2 Diabetes

The Type 2 Diabetes Learning Zone comprises the Type 2 Diabetes Mellitus Knowledge Centre containing current epidemiology statistics, current diagnosis criteria from WHO and ADA, treatment options and latest guidelines; a Therapy Focus area compiling material on emerging insulin/incretin treatment combinations; and two free CME activities, which are the EACCME-accredited ‘Role of Newer Therapies for Type 2 Diabetes in Combination with Insulin’ (worth 1 CME credit) and ‘Best Practice in Type 2 Diabetes: Update on Incretin Therapies in Combination with Insulin’. 

Milurit® | Dosage

Milurit® | Adult Dosage

Tbl. 100 mg: Carboxymethylstärke, Natriumsalz, Magnesiumstearat, Talkum, Povidon, Kartoffelstärke, Lactose, Tbl. 300 mg: Mikrokristalline Cellulose, Carboxymethylstärke, Natriumsalz, Gelatine, Magnesiumstearat, Hochdisperses Siliciumdioxid.

Milurit® | Precautions, Reactions and Contraindications

Milurit® | Special Precautions

Milurit® | Adverse Reactions

Milurit® | Adverse Reactions

A 30

Related Drugs - Angiology

Back to top